Published in J Clin Endocrinol Metab on August 01, 1978
A new look at electrolyte transport in the distal tubule. Annu Rev Physiol (2011) 1.13
Tissue kallikrein activation of the epithelial Na channel. Am J Physiol Renal Physiol (2012) 1.08
Urinary kallikrein excretion in essential and mineralocorticoid hypertension. J Clin Invest (1980) 0.94
Amiloride inhibits mammalian renal kallikrein and a kallikrein-like enzyme from toad bladder and skin. J Clin Invest (1980) 0.92
Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans. J Clin Invest (2005) 0.92
Modulation of the BP response to diet by genes in the renin-angiotensin system and the adrenergic nervous system. Am J Hypertens (2010) 0.88
Early increases in renal kallikrein secretion on administration of potassium or ATP-sensitive potassium channel blockers in rats. Br J Pharmacol (1999) 0.78
A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept. Pharmaceuticals (Basel) (2010) 0.75
Evidence for environmental familiality of kallikrein excretion in Utah kindreds. West J Med (1986) 0.75
Effect of metoprolol on 24-hour urinary excretion of adrenal steroids and kallikrein in patients with essential hypertension. Br J Pharmacol (1984) 0.75
A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum (1992) 4.50
Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features. Hum Pathol (1990) 3.22
Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem (1986) 2.95
Kinins stimulate net chloride secretion by the rat colon. Br J Pharmacol (1982) 2.26
Reduction of renal function by newer nonsteroidal anti-inflammatory drugs. Am J Med (1978) 1.96
von Recklinghausen's disease and pheochromocytomas. J Urol (1999) 1.92
Continuous measurement of tissue blood flow by laser-Doppler spectroscopy. Am J Physiol (1977) 1.82
Stability of blood pressure rank and urinary kallikrein concentration in childhood: an eight-year follow-up. Circulation (1978) 1.75
Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydranize metabolites. Clin Pharmacol Ther (1975) 1.75
Decreased taste sensitivity after D-penicillamine reversed by copper administration. Lancet (1967) 1.69
Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: comparison with CT and MRI. J Nucl Med (1993) 1.65
Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N Engl J Med (1999) 1.65
Plasma metanephrines in the diagnosis of pheochromocytoma. Ann Intern Med (1995) 1.64
Sipple's syndrome: medullary thyroid carcinoma, pheochromocytoma, and parathyroid disease. Studies in a large family. NIH conference. Ann Intern Med (1973) 1.64
Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis. Am J Med (1976) 1.55
Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci (1981) 1.55
Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats. J Lab Clin Med (1997) 1.52
Prostaglandin biosynthesis by rabbit renomedullary interstitial cells in tissue culture. Stimulation by angiotensin II, bradykinin, and arginine vasopressin. J Clin Invest (1977) 1.50
Mediators of the secretory response to kinins. Br J Pharmacol (1984) 1.49
Determination of metanephrines in plasma by liquid chromatography with electrochemical detection. Clin Chem (1993) 1.47
Human amyloid protein: chemical variability and homogeneity. J Histochem Cytochem (1971) 1.45
Degradation of apolipoprotein B-100 of human plasma low density lipoproteins by tissue and plasma kallikreins. J Biol Chem (1984) 1.44
Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. J Clin Invest (1988) 1.41
The radioimmunoassay of human urinary kallikrein and comparisons with kallikrein activity measurements. J Clin Endocrinol Metab (1980) 1.39
Collagen synthesis in human keloid and hypertrophic scar. Surg Forum (1971) 1.38
Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. Ann Intern Med (1988) 1.37
Elevated urinary prostaglandins and the effects of aspirin on renal function in lupus erythematosus. Ann Intern Med (1978) 1.33
Effects of dietary sodium and of acute saline infusion on the interrelationship between dopamine excretion and adrenergic activity in man. J Clin Invest (1974) 1.32
Urinary kallikrein excretion in hypertensive man. Relationships to sodium intake and sodium-retaining steroids. Circ Res (1974) 1.31
Biochemical and pharmacologic effects of alpha-methyltyrosine in man. J Clin Invest (1968) 1.31
The effects of injected norepinephrine and sympathetic nerve stimulation in hypothyroid and hyperthyroid dogs. J Pharmacol Exp Ther (1965) 1.29
Pheochromocytoma: evaluation, diagnosis, and treatment. World J Urol (1999) 1.29
Isozymes of rat urinary kallikrein. Biochem Pharmacol (1979) 1.27
Urinary kallikrein excretion in normal man. Relationships to sodium intake and sodium-retaining steroids. Circ Res (1974) 1.25
Increased protocollagen proline hydroxylase activity in sclerodermatous skin. Arch Dermatol (1971) 1.22
Vasopressin-stimulated prostaglandin E biosynthesis in the toad urinary bladder. Effect of water flow. J Clin Invest (1977) 1.22
Evidence for the existence of atrial natriuretic factor-containing neurons in the rat brain. Neuroendocrinology (1985) 1.21
Inhibition of short-circuit current in toad urinary bladder by inhibitors of glandular kallikrein. Am J Physiol (1980) 1.20
Direct measurement of the rate of collagen synthesis in skin. Clin Chim Acta (1969) 1.19
Clinical evaluation of impedance cardiography. Clin Physiol (1986) 1.18
Renin-angiotensin system modulates renal bradykinin production. Am J Physiol (1996) 1.18
Human serum dopamine- -hydroxylase. Relationship to hypertension and sympathetic activity. Circ Res (1973) 1.18
Murine amyloid fibril protein: isolation, purification and characterization. J Histochem Cytochem (1971) 1.17
Comparison of techniques for measuring baroreflex sensitivity in man. Circulation (1982) 1.16
Histaminase activity: a biochemical marker for medullary carcinoma of the thyroid. Am J Med (1972) 1.16
Molecular biology of tissue kallikrein. Biochem J (1988) 1.13
Prostaglandin E2 biosynthesis by rabbit renomedullary interstitial cells in tissue culture. Mechanism of stimulation by angiotensin II, bradykinin, and arginine vasopressin. J Biol Chem (1977) 1.10
Familial medullary carcinoma of the thyroid, adrenal pheochromocytoma and parathyroid hyperplasia. A syndrome of multiple endocrine neoplasia. Radiology (1973) 1.10
Role of neutral endopeptidase in the metabolism of endothelin. Hypertension (1992) 1.10
Indomethacin-responsive hypercalcemia in a patient with renal-cell adenocarcinoma. N Engl J Med (1974) 1.10
Rat renal interstitial bradykinin, prostaglandin E2, and cyclic guanosine 3',5'-monophosphate. Effects of altered sodium intake. Hypertension (1994) 1.10
Effects of mineralocorticoids, altered sodium intake, and adrenalectomy on urinary kallikrein in rats. Circ Res (1972) 1.08
Role of calcium ions in kinin-induced chloride secretion. Br J Pharmacol (1984) 1.08
Amyloid. VI. A comparison of two morphologic components of human amyloid deposits. J Histochem Cytochem (1968) 1.08
Identification of a new tissue-kallikrein-binding protein. Biochem J (1986) 1.08
Circulatory, plasma catecholamine, cortisol, lipid, and psychological responses to a real-life stress (third molar extractions): effects of diazepam sedation and of inclusion of epinephrine with the local anesthetic. Psychosom Med (1982) 1.06
Identification of tissue kallikrein in brain and in the cell-free translation product encoded by brain mRNA. J Biol Chem (1983) 1.05
Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure. Circulation (1995) 1.05
Bradykinin B2 receptor modulates renal prostaglandin E2 and nitric oxide. Hypertension (1997) 1.04
Management of hereditary pheochromocytoma in von Hippel-Lindau kindreds with partial adrenalectomy. J Urol (1999) 1.04
Serum histaminase and calcitonin levels in medullary carcinoma of the thyroid. Lancet (1972) 1.03
Regulation of postocclusive hyperemia by endogenously synthesized prostaglandins in the dog heart. J Clin Invest (1975) 1.03
Phenotypes of 'null' lymphoid cells in human blood. Scand J Immunol (1979) 1.02
Prostaglandins are overproduced by the kidneys and mediate hyperreninemia in Bartter's syndrome. Trans Assoc Am Physicians (1976) 1.02
Response of plasma histaminase activity to small doses of heparin in normal subjects and patients with hyperlipoproteinemia. J Clin Invest (1973) 1.01
Altered urinary kallikrein excretion in rats with hypertension. Circ Res (1972) 1.01
Surgical management of pheochromocytoma with the use of metyrosine. Ann Surg (1990) 1.00
Kallikrein localization in rodent salivary glands and kidney with the immunoglobulin-enzyme bridge technique. J Histochem Cytochem (1979) 1.00
Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects. Ann Intern Med (1977) 0.99
Kinin effects on chloride secretion do not require eicosanoid synthesis. Br J Pharmacol (1984) 0.99
Derivation of urinary dopamine from plasma dihydroxyphenylalanine in humans. Clin Sci (Lond) (1993) 0.98
Differential effects of testosterone, thyroxine, and cortisol on rat submandibular gland versus renal kallikrein. Endocrinology (1983) 0.98
Malignant pheochromocytoma. Chromaffin granule transmitters and response to treatment. Hypertension (2000) 0.97
A direct radioimmunoassay of rat urinary kallikrein and comparison with other measures of urinary kallikrein activity. J Lab Clin Med (1979) 0.96
Urinary kallikrein excretion in hypertension. Circ Res (1972) 0.96
The kallikrein-kinin system and the kidney. Annu Rev Physiol (1984) 0.96
Stimulation of renal interstitial bradykinin by sodium depletion. Am J Hypertens (1993) 0.96
The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition. J Clin Invest (1978) 0.95
Clonidine suppression testing in essential hypertension. Ann Intern Med (1985) 0.95
Urinary kallikrein excretion in spontaneously hypertensive rats. Circ Res (1975) 0.95
Circulatory control mechanisms in vasodepressor syncope. Am Heart J (1982) 0.93
Amiloride inhibits mammalian renal kallikrein and a kallikrein-like enzyme from toad bladder and skin. J Clin Invest (1980) 0.92
The effect of converting enzyme inhibition with SQ20,881 on plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man. Hypertension (1980) 0.92
Release of immunoreactive-neuropeptide by rat platelets. Biochem Biophys Res Commun (1988) 0.92
Urinary excretion rate of endothelin-1 in patients with essential hypertension and salt sensitivity. Kidney Int (1994) 0.92
Urinary kallikrein in dogs with constriction of one renal artery. Proc Soc Exp Biol Med (1976) 0.92
Familial aggregation of urinary kallikrein concentration in childhood: relation to blood pressure, race and urinary electrolytes. Am J Epidemiol (1976) 0.92
Plasma l-[3H]norepinephrine, d-[14C]norepinephrine, and d,l-[3H]isoproterenol kinetics in essential hypertension. J Clin Invest (1983) 0.92